Haeseong Park

7PUBLICATIONS
101CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 18, 2024
First-in-Human Dose-Escalation Study of Fianlimab, an Antilymphocyte Activation Gene-3 Antibody, with Cemiplimab in Patients with Advanced Malignancies.

Nehal J Lakhani, Kyriakos P Papadopoulos, Melissa Lynne Johnson

|Oct 06, 2023
A Pilot Study of Paricalcitol plus Nanoliposomal Irinotecan and 5-FU/LV in Advanced Pancreatic Cancer Patients after Progression on Gemcitabine-Based Therapy.

Patrick M Grierson, Rama Suresh, Benjamin Tan

|Aug 09, 2023
Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial.

Georg Pfeiler, Dominik Hlauschek, Erica L Mayer

|Apr 20, 2023
Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2-Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid Correlates.

Daniel A King, Amber R Smith, Gino Pineda

|Jan 05, 2023
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline.

Manish A Shah, Erin B Kennedy, Ashley E Alarcon-Rozas

|May 05, 2022
First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response.

Timothy A Yap, Justin F Gainor, Margaret K Callahan

Pageof 2

Frequent Collaborators

2 joint publications

Timothy A Yap

2 joint publications

Kyriakos P Papadopoulos

2 joint publications

Daniel A King

1 joint publications

Justin F Gainor